These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24649958)

  • 21. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repositioning for rare diseases: Knowledge-based success stories.
    Scherman D; Fetro C
    Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular target engagement: a new paradigm in drug discovery.
    Babic I; Kesari S; Nurmemmedov E
    Future Med Chem; 2018 Jul; 10(14):1641-1644. PubMed ID: 29957028
    [No Abstract]   [Full Text] [Related]  

  • 25. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically active metabolites in drug discovery.
    Sun S; Wesolowski SS
    Bioorg Med Chem Lett; 2021 Sep; 48():128255. PubMed ID: 34245850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tools for in silico target fishing.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
    Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic approaches to small-molecule discovery in chemical biology.
    Wagner BK; Dey M
    Cell Chem Biol; 2021 Mar; 28(3):245. PubMed ID: 33740431
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening technologies for small molecule discovery: the state of the art.
    Janzen WP
    Chem Biol; 2014 Sep; 21(9):1162-70. PubMed ID: 25237860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro screening for drug repositioning.
    Wilkinson GF; Pritchard K
    J Biomol Screen; 2015 Feb; 20(2):167-79. PubMed ID: 25527136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
    Ravikumar B; Timonen S; Alam Z; Parri E; Wennerberg K; Aittokallio T
    Cell Chem Biol; 2019 Nov; 26(11):1608-1622.e6. PubMed ID: 31521622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PubChem 2019 update: improved access to chemical data.
    Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
    Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.
    Daminelli S; Haupt VJ; Reimann M; Schroeder M
    Integr Biol (Camb); 2012 Jul; 4(7):778-88. PubMed ID: 22538435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
    Jin G; Wong ST
    Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug repurposing: translational pharmacology, chemistry, computers and the clinic.
    Issa NT; Byers SW; Dakshanamurthy S
    Curr Top Med Chem; 2013; 13(18):2328-36. PubMed ID: 24059462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and opportunities of drug repositioning.
    Novac N
    Trends Pharmacol Sci; 2013 May; 34(5):267-72. PubMed ID: 23582281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.